Sonnet BioTherapeutics Holdings, Inc.

Ownership Transactions Reported by 11 Insiders

Symbol
SONN on Nasdaq
Industry
Pharmaceutical Preparations
Location
100 Overlook Center, Suite 102, Princeton, NJ

There are no Buy or Sell transactions made by insiders since 1/6/2024

Sonnet BioTherapeutics Holdings, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
John Markey 10%+ Owner $131K Aug 7, 2023
Pankaj Mohan Chairman, President and CEO, Director $10.8K Dec 11, 2023
Raghu Rao Director $1.65K Dec 11, 2023
John K. Cini Chief Scientific Officer $1.48K Dec 11, 2023
Susan Dexter Chief Technical Officer $1.15K Dec 11, 2023
John Harry Cross III Chief Financial Officer $1.11K Dec 11, 2023
Richard T. Kenney Chief Medical Officer $962 Dec 11, 2023
Nailesh Bhatt Director $383 Dec 11, 2023
Albert D. Dyrness Director $376 Dec 11, 2023
Lori McNeill Director $276 Dec 11, 2023
Donald J. Griffith Director $263 Dec 11, 2023

Recent Insider Transactions by Companies or Individuals for Sonnet BioTherapeutics Holdings, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.